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4ABSTRACT
Background: :
Perinatal depression is one of the most common complications of
childbearing.
Approximately 10 to 15% of women experience a clinically significant
major depressive episode during pregnancy or the early postpartum period
(Bennett, Einarson, Taddio, Koren, & Einarson, 2004b; Epperson, 1999;
Gavin, Gayner, Lohr, Meltzer-Brody, Gartlehner, & Swinson, 2005; O’Hara
& Swain, 1996). These prevalence estimates predominantly reflect rates of
depressive symptoms in developed countries; there is evidence that rates of
depression vary more widely in non-developed countries (Halbreich &
Karkun, 2006). In addition to the distress and impairment experienced by
depressed women, depression during this time period is associated with
further adverse outcomes for both mother and child. Women who
experience perinatal depressive episodes are at increased risk for subsequent
episodes of both postpartum and non-postpartum depression (Cooper &
Murray, 1995).
Anxiety symptoms are frequently reported by pregnant women and are
often considered as part of the normal psychic experiences of pregnancy,
5especially if they are focused on the baby's health or on maternal
competencies.
The emotional image of the baby inside is what is called the mother fetus
relationship.
Cranley (1981) describes the nature of mother’s experiences as ‘physical
and kinesthetic awareness of the fetus’, and an ‘intellectual knowledge of
her child’.
Nowadays, the concept of prenatal attachment is more accurately defined
(Righetti, 2003) and it generally refers to the maternal–fetal relationship,
which normally develops during the pregnancy; it represents the earlier
internalized representation of the fetus that both parents typically acquire
and elaborate. Pregnancy can also represent a crisis period for many
women, with manifest effect on antenatal attachment. Condon and
Corkindale (1997) explore the hypothesis that feelings of anxiety or
depression and lack of social support would be an interference issue in the
development of maternal antenatal attachment. Women characterized by
low attachment are associated with high levels of depression and anxiety,
weak external social support, and high control and criticism in the partner
relationship.
6Aims:
The aims of this thesis were: 1)to assess association between antenatal
attachment and demographic characteristics. 2) to investigate the role of
maternal attachment (as MAAS) on the development of depression
(EPDS>12) ,  anxiety symptoms  (STAI-Y >40) and risk factors (PDPI-R)
during pregnancy. 3) to assess the specific role of antenatal attachment  as
risk factor for depression (EPDS>12),  as anxiety symptoms (STAI>40)
during pregnancy.
.
Methods:
A sample of pregnant  (N= 456) women was recruited as part of a larger
study conducted at Pisa in the framework of the Perinatal Research and
Screening Unit Study (PND-ReScU). The Perinatal Depression-Research and
Screening Unit (PND-ReScU) is based on an ongoing collaboration between
the Department of Obstetrics and Gynecology and the Department of
Psychiatry, Neurobiology, Pharmacology, and Biotechnologies of the
Azienda Ospedaliera Universitaria Pisana. The primary aim of the PND-
ReScU is to evaluate the effectiveness of screening for early identification
and the intervention strategies to reduce mood disorders in the perinatal
period. Furthermore, PND-ReScU aims at defining a battery of instruments
that can be easily administered in a primary prevention setting.
7Women were recruited for the study during pregnancy, at the time of
delivery of the pregnancy book, or in the immediate post-partum period
(during hospitalization).
Instruments:
 Symptoms of maternal depression were assessed using the 10-item
Edinburgh Postnatal Depression Scale (Cox et al., 1987). The Post-partum
Depression Predictors Inventory-Revised (PDPI-R) (Beck, 2002) was used to
identify the risk factors for PPD. Prenatal maternal attachment were
assessed using  the Maternal Antenatal Attachment Scale  (MAAS).
Maternal and paternal antenatal attachment scales (MAAS; Condon, 1993).
Anxiety symptoms were assessed using STAI-Y ( state trait anxiety
Inventory form Y-1.)
Statistical analysis:
Data are presented as means (standard deviations), or percentages.
Chi-square tests were used to compare percentages and
ANOVA were used to compare mean scores.
Using analysis of variance (ANOVA) was able to compare two or more
groups of data comparing the internal variability in these groups with the
variability between groups.
8To check the intensity and direction of the relationships between
depression, anxiety, attachment to the fetus and risk factors, was
performed Pearson bivariate correlation.
Analyses were conducted using SPSS, version 15.
Results:
Our sample is composed by 456 women: among them, 393 (86.2%) of
Italian nationality and 401 (87.9%) experiencing a spontaneous pregnancy.
Moreover, 61.6% of the sample is composed of women in their first
pregnancy.
At T0, we can observe that 4.8% of women have an high score on EPDS
(EPDS ≥13) while at T1 At the percentage of the output decreases to .9%.
At T2 decreases further to 4%. while the T3 is increased up to 1.1%.T0, the
prevalence of anxiety is 18%, while we can observe that the percentage
decrease at the next T: T1 (6.1%), T2 (4.4%), T3 (3.9%). the average of the
MAAS total scores at T2 was 76.95 ± 6.3, while at T3, the average is 78.54 ±
6.29. Considering the MAAS Preoccupation subscales at T2 the average is
28.12 ± 4.2 and 29.33 ± 4.21 at T3. Considering the Quality of Attachment
subscale MAAS, at T2, the average is 47.2 ± 3.29, while the T3 is 47.71 ±
2.98. Association between depression during pregnancy, good antenatal
attachment , anxiety symptoms and risk factors is reported in tab 2,3,4,5.
9In our sample we don’t find any association between antenatal maternal
attachment and demographic characteristics except for women in their
first pregnancy in which we discover higher MAAS scores than other
women in sample. Correlation between antenatal attachment, anxiety,
depression and risk factors during pregnancy is reported in tab.7
Conclusions:
Many of the physiological sensations that occur during pregnancy closely
resemble anxiety symptoms; thus, these disorders may be masked in
pregnant women. For this reason it is essential that treatment providers in
obstetric offices, primary care settings, and mental health clinics be
attuned to the signs of anxiety disorders (Weisberg and Paquette, 2002).
Carrying out antenatal screening of established risk factors and accurate
evaluation of attachment during pregnancy may help to plan adequate
treatment in order to prevent possible postpartum distress outcomes.
Further studies are needed to replicate our findings and to clarify the role
of  pre/post natal attachment during pregnancy and its link with Post-
Partum Depression in order to identify a specific subgroup of women
warranting special attention.
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1. INTRODUCTION
1.1 Epidemiological Date
Perinatal depression is one of the most common complications of
childbearing.
Approximately 10 to 15% of women experience a clinically significant
major depressive episode during pregnancy or the early postpartum period
(Bennett, Einarson, Taddio, Koren, & Einarson, 2004b; Epperson, 1999;
Gavin, Gayner, Lohr, Meltzer-Brody, Gartlehner, & Swinson, 2005; O’Hara
& Swain, 1996). These prevalence estimates predominantly reflect rates of
depressive symptoms in developed countries; there is evidence that rates of
depression vary more widely in non-developed countries (Halbreich &
Karkun, 2006). In addition to the distress and impairment experienced by
depressed women, depression during this  period is associated with further
adverse outcomes for both mother and child. Women who experience
perinatal depressive episodes are at increased risk for subsequent episodes
of both postpartum and non-postpartum depression (Cooper & Murray,
1995).
Prenatal depression is associated with increased risk for negative birth
outcomes, including preterm labor, low birth weight, and intrauterine
growth restriction (Grote, Bridge, Gavin, Melville, Iyengar, & Katon, 2010).
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Maternal depression during the postpartum period is also a risk factor for a
range of adverse child outcomes, including behavioral problems and
impaired cognitive development (Grace, Evindar, & Stewart, 2003).
1.2 Risk Factors of Postnatal Depression (PND)
Despite the stereotype that the perinatal phase is a period of happiness,
women frequently experience adjustment difficulties and depressive
symptoms during pregnancy and in the postpartum period. Reviews and
meta-analyses published on postnatal depression (PND) estimate that in
Western countries it affects 10% to 15% of women (Beck, 2001; O’Hara and
Swain, 1996). Recently, meta-analysis of the Agency for Healthcare
Research and Quality estimated that the prevalence of major or minor
depression in pregnancy ranges from 8.5% to 10.0% while in the first
postpartum year it ranges from 6.5% to 12.9% (Gaynes et al., 2005). These
figures are comparable to those seen in non-childbearing women (O’Hara
et al., 1991).
Although every woman is potentially at risk of developing PND, women
who present specific risk factors have a significantly increased risk of
becoming depressed after delivery. These risk factors are widely studied in
literature (Kitamura et al., 1993; Glangeaud-Freudenthal and Boyce, 2003;
Robertson et al., 2004) and meta-analyses (Beck, 2001; O’Hara and Swain,
12
1996) have been carried out to estimate the effect size of each of them.
Currently, the known risk factors have been classified, according to their
effect size, into three categories: strong-moderate, moderate, and small.
The strongest predictors of PND are the experience of depression or
anxiety during pregnancy or a previous depressive illness (Ryan et al., 2005;
Robertson et al., 2004). In addition to these predictors, life stress and lack
of social support have a moderate-severe effect size; psychological factors
and marital problems have a moderate effect size, while obstetric factors
and socioeconomic status have a small effect size (Robertson et al., 2004).
As regards psychiatric risk factors, when anxiety is considered as a
dimensional characteristic clinically assessed or measured by a score on a
rating scale, the findings in the literature are discrepant. Precursor studies
suggested that anxiety during pregnancy increased the risk of PND (Dalton,
1971; Tod, 1964; Heron et al., 2004) while others did not confirm this
association (Pitt B., 1968). In a recent study Austin et al. (2007) have
demonstrated that women with high antenatal BMWS scores (scale used to
assess trait cognitive anxiety) were 2.6 times more likely to have probable
PND than those with low scores (Austin et al., 2007). Antenatal anxiety has
been found to be a significant predictor of postnatal depression in three
meta-analysis (O’Hara and Swain, 1996; Beck, 2001; Robertson et al.,
2004).
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Although the role of anxiety symptoms on the development of PND has
already been studied in literature (Heron et al., 2004; Sutter-Dallay et al.,
2004; Skouteris et al., 2009), the link between anxiety disorders (AD)
defined as diagnostic categories and PND, has received only a little specific
attention. Moreover, in most studies there were methodological
limitations such as small sample sizes and the lack of adjustment for
confounding factors. In particular, most studies did not take into account
the strong co morbidity between mood disorders and AD, and thus did not
investigate whether pregnancy AD could increase the risk of PND,
regardless of the existence of pregnancy depression.
In a large sample of women Sutter-Dallay (2004) assessed whether
pregnancy AD is an independent risk factor for the occurrence of intense
postnatal depressive symptoms; these authors found that women
presenting  pregnancy AD were four times more likely to present also
postnatal depression at the 6th week, than those without. Further, as
literature suggests, no studies have examined the predictive role of a
specific diagnosis of anxiety disorder in post-partum depression.
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1.3 Treatments for post partum depression
Given the prevalence of perinatal depression and the adverse effects this
disorder has on women and their children, the identification of effective
treatments for this disorder has important public health implications.
Although there is a great evidence for the efficacy of both antidepressant
medication and psychological interventions for depression (Joffe, Sokolov
& Streiner, 1996 and Cuijpers, van Straten, Andersson, & van Oppen, 2008 )
. For example, in an attempt to limit fetal exposure, antidepressants may
be prescribed below therapeutic dosage levels (Bennett, Einarson, Taddio,
Koren, & Einarson, 2004a).
This problem is complicated further by the fact that most women actually
require higher doses of antidepressant medication during pregnancy
(Dawes & Chowienczyk, 2001; Hostetter, Stowe, & Strader, 2000; Wisner,
Perel, & Wheeler, 1993). Concerns regarding effects of infant exposure to
antidepressant medication via breast milk may also lead clinicians to
prescribe inadequate doses of these medications during the postpartum
period (Epperson, Anderson, & McDougle, 1997; Epperson, Jatlow,
Czarkowski, &
Anderson, 2003). Biological and psychosocial changes that occur in the
context of pregnancy and parenting, including sleep deprivation,
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disruptions to the hormonal balance, alterations to HPA axis functioning,
and changes to interpersonal relationships, introduce challenges that may
affect the efficacy of both pharmacological and psychotherapeutic
interventions (Dennis & Ross, 2005; Kammerer, Taylor, & Glover, 2006).
Efficacy of psychological interventions for depression may also be reduced
among women who have had previous pregnancy losses, complications, or
traumatic deliveries, as they may experience post-traumatic stress disorder
or other co morbid anxiety disorders (Forray, Mayes, Magriples, &
Epperson, 2009).
There are also differences in the acceptability of interventions, particularly
among women who are pregnant or breastfeeding: the majority of women
indicate a preference for psychological interventions to antidepressant
medication during both pregnancy and the postpartum period, and the
overall acceptability of antidepressant medication among these groups is
low (Chabrol, Teissedre, Armitage, Danel, & Walburg, 2004; Kim et al.,
2011). Thus, identification of efficacious interventions, particularly
psychological interventions, for this population is an important and
growing area of research.
Two meta-analytic reviews of psychological treatments for postpartum
depression have found these interventions to be superior to routine care
or control conditions. A Cochrane review of psychological and psychosocial
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interventions for postpartum depression found that, compared to routine
care, these interventions were associated with a 30% reduction in relative
risk for depressive symptomatology (Dennis & Hodnett, 2007).
Cuijpers, Brännmark, and van Straten (2008) conducted a meta-analysis of
17 studies in which a psychological intervention initiated during the
postpartum period was compared to a control or active treatment
condition. They reported that psychological interventions were superior to
control conditions, with an overall effect size in the moderate range.
Many studies of interventions for this population are either open trials or
do not include a treatment control condition, we chose not to restrict
these analyses to studies in which interventions were compared to a
control condition. However the possibility that effect sizes calculated from
these studies may reflect natural symptom remission over time, we also
compared active treatments to control conditions in studies where it was
possible to do so.
1.4 The Maternal Attachment
In the last two decades, psychologists had progressively structured the
concept of the mother–fetus relationschip as the complex emotional
internal image of the unborn baby, that the mother acquires and
increments throughout her pregnancy (Rapheal-Leff, 1986; Righetti, 1996;
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Righetti & Sette, 2000; Stainton, 1985). Cranley (1981) describes the nature
of the mother’s experiences as ‘physical and kinesthetic awareness of the
fetus’, and an ‘intellectual knowledge of her child’.
Nowadays, the concept of antenatal/prenatal attachment is more
accurately defined (Righetti, 2003) and it generally refers to the maternal–
fetal relationship, which normally develops during pregnancy; it represents
the earlier internalized representation of the fetus that both parents
typically acquire and elaborate.
Condon (1993) suggests a way of understanding attachment in terms of
quality of the affective experiences (closeness/distance,
tenderness/irritation, pleasure in interaction, distress at fantasized loss,
and conceptualization of the fetus as a ‘little person’) and intensity of
preoccupation (amount of time spent thinking about, talking to, dreaming
about or palpating the fetus).
Researchers have demonstrated that prenatal attachment develops
regardless of maternal age (Bloom, 1995), although middle-aged women
aged over 35 show significantly lower prenatal attachment scores.
Furthermore, no significant differences are found in prenatal attachment
levels between primiparous and multiparous groups of women (Condon &
Esuvaranathan, 1990).
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The favourable prospective use of antenatal attachment is underlined by
Condon’s statements (1997): ‘Maternal–fetal attachment is of a potential
significance from both theoretical and clinical perspectives. It represents
the development of the earliest, most basic form of human intimacy
involving an object characterized by a curious admixture of fantasy and
reality.’
Pregnancy can also represent a critical period for many women, with
manifest effect on antenatal attachment. Condon and Corkindale (1997)
explore the hypothesis that feelings of anxiety or depression and lack of
social support would be an interference
issue in the development of maternal antenatal attachment. Women
characterized by low attachment are associated with high levels of
depression and anxiety, weak external social support, and high control and
criticism in the partner relationship. From a clinical perspective, the
incidence and the implication of low levels of prenatal attachment are also
investigated; approximately 8% of women develop minimal attachment to
their unborn child (Condon, 1986; Condon, 1987). Pollock and Percy (1999)
found an association between the low attachment group and self-reported
risk to the fetus and dimension of personality disorder. Thus, it seems not
implausible that the antenatal attachment may be of critical importance
for the early mother–infant relationships.
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Maternal feelings and sensitivity towards the child develop continuously
throughout pregnancy (Leifer, 1997), and a loving relationship with the
fetus would continue to be a good, sensitive interaction postnatally. In a
study of 100 pregnant mothers, Siddiqui and Hagglof (2000) indicate that
mothers who experienced greater affection during pregnancy and
fantasized more about the unborn babies at about 12 weeks postpartum,
showed more overall involvement during interaction, in particular
in stimulating their infants. Consequently, interventions which result in
better antenatal attachment may have durable positive consequences.
The role of antenatal care, ultrasound scanning technique in particular, has
not been satisfactorily investigated, although fetal ultrasound screening
has progressively become routine practice in many countries. Studies from
the early 1980s (Reading, Cox,
Sledmere, & Campbell, 1984) demonstrated that women liked the moving
image of scans, above all ‘seeing the baby on scan is a high spot of the
pregnancy, an event to be shared with the baby’s father and siblings’
(Marteau & Richards, 1996, p.122). In fact, women generally consider
ultrasound a pleasant experience and one of the best aspects of their
antenatal care (Brown, Lumley, Small, & Astbury, 1994); moreover, women
and their partners find ultrasound very attractive because it offers a visual
20
confirmation of pregnancy, and it represents a new form of contact with
the unborn baby (Clement, Wilson, & Sikorski, 1998).
21
2. AIMS OF THE STUDY
This thesis has three aims:
1)to assess association between antenatal attachment and demographic
characteristics
2) to investigate the role of maternal attachment (as MAAS) on the
development of depression  (EPDS>12) ,  anxiety symptoms  (STAI-Y >40)
and risk factors (PDPI-R) during pregnancy
3) to assess the specific role of antenatal attachment as risk factor for
depression (EPDS>12),  and anxiety symptoms (STAI>40) during pregnancy
22
3. METHOD
3.1 Participants
A sample  of 456 pregnant women was recruited as part of a larger study
conducted at Pisa in the framework of the Perinatal Research and
Screening Unit Study (PND-ReScU). The Perinatal Depression-Research and
Screening Unit (PND-ReScU) is based on an ongoing collaboration between
the Department of Obstetrics and Gynecology and the Department of
Psychiatry, Neurobiology, Pharmacology, and Biotechnologies of the
Azienda Ospedaliera Universitaria Pisana. The primary aim of the PND-
ReScU is to evaluate the effectiveness of screening for early identification
and the intervention strategies to reduce mood disorders in the perinatal
period. Furthermore, PND-ReScU aims at defining a battery of instruments
that can be easily administered in a primary prevention setting strategy.
The women  included in this study were recruited during pregnancy when
the pregnancy book was delivered to them. Central to our recruitment plan
was a letter to be given to each pregnant woman who came to the local
health service to receive a booklet of information  issued by the region of
Tuscany  describing the various aspects of pregnancy and maternal health.
This letter was meant to provide a brief description of perinatal depression
and inform women about the possibility of participating in a study aimed at
evaluating risk factors for this condition. The Study recruitment began in
23
September 2009 and ended in august 2011. Study should last 24 months
with a recruitment period of 6 months. To be included in the study,
Women had to be at the third month of their pregnancy, be willing to sign
an informed consent statement and be available to be contacted by phone.
Exclusion criteria for the study were age 18 years, poor knowledge of the
Italian language or other limitations to communication and no fixed
residence. The Ethics Committee of the Azienda Ospedaliera Universitaria
Pisana approved the study protocol and the assessment procedures. The
Committee also required the provision of psychological counseling for
women with mild depressive symptomatology and/or for all women who
requested it. Provisions of drug treatment for women with
moderate/severe depression, were also provided according to
international guidelines (U.S. Food and Drug Administration, 1979;
American Academy of Pediatrics, 2000). All subjects were written in the
informed consent providing participants with a full description of the study
and the opportunity to ask questions. The Ethics Committee allowed us to
collect information only after the informed consent statement was signed,
as prescribed the Italian law (art. n. 675 of December 31, 1996) on privacy.
Therefore, socio-demographic characteristics of women who refused to
participate in the study are not available. This study was supported by the
Italian Ministry of Health.
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3.2 Instruments
 Several instruments were administered to evaluate a broad range of
different aspects related to the perinatal period that might represent
potential risk factors for the development of PND.
Symptoms of maternal depression were assessed using the 10-item
Edinburgh Postnatal Depression Scale (Cox et al., 1987). Originally designed
as a screening instrument for postnatal depression, the EPDS has been
since then validated for use during pregnancy (Murray and Cox, 1990). The
EPDS  is a 10-item self-report scale designed as a screening instrument for
postnatal depression but has also been validated in non-postnatal women
(Cox et al., 1987). Each item is scored on a four-point scale (0–3), the
minimum and maximum scores being 0 and 30, respectively. Five of the
items explore dysphoric mood, two explore anxiety and three assess guilt
and suicidal thoughts. The total is calculated by summing up the item
scores. A score of 13 and above is used to identify probable cases with a
sensitivity of 86% and a specificity of 78% (Cox et al., 1987). The scale does
not provide a clinical diagnosis of depression, but a score above 13 is
widely used to indicate the presence of probable depressive disorder. The
EPDS rates the intensity of depressive symptoms present over the previous
7 days (see Appendix 2 for a description of the items). A cut-off score of 13
25
has been found to identify most seriously depressed women, although in
case of a score of 9 or more, clinical assessment has been recommended
(Cox et al., 1983). In 1992, the EPDS was translated into Italian and was
found to have good psychometric properties (Carpiniello et al., 1997).
When women exceeded the threshold score (total scores ≥13) of EPDS,
suggesting the probable presence of depression, we have re-administered
section A of SCID to confirm the diagnosis of depressive disorders. Scores
on EPDS item 3, “blamed myself unnecessarily”, item 4, “anxious or worried
for no good reason”, and item 5, “scared or panicky for no very good
reason”, were extracted for further analysis. These items were clustered as
“Anxiety EPDS”. Scores on EPDS item 1, “I have been able to laugh and see
the funny side of things”, item 2, “I have looked forward with enjoyment to
things”, and item 8, “I have felt sad or miserable”, were extracted for
further analysis. These items were clustered as “Depression EPDS”.
Information on socio-economic status was drawn from the Postpartum
Depression Predictors Inventory-Revised (PDPI-R) (Beck, 2002), which is a
self-report instrument designed to identify the risk factors for postpartum
depression. The PDPI-R categorizes socio-economic status on 3 levels: -low,
medium, and high, without providing anchor points related to the income
per year. The 13 PDPI-R factors are (1) marital status, (2) socio- economic
status, (3) self-esteem, (4) prenatal depression, (5) prenatal anxiety, (6)
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unwanted/unplanned pregnancy, (7) history of previous depression, (8)
social support, (9) marital dissatisfaction, (10) life stress, (11) childcare
stress, (12) infant temperament, and (13) maternity blues. The first 10
predictors comprise the prenatal version of the PDPI-R. The last 3 risk
factors are specific to the postpartum period. The total score on the
prenatal version of the PDPI-R ranges between 0 and 32, while the PDPI-R
Full Version (Prenatal plus Postpartum Versions) is used after delivery and
includes all 10 factors of the Prenatal Version plus three additional risk
factors: childcare stress, infant temperament and maternity blues. The total
score of the Full Version ranges between 0 and 39 (Beck et al., 2006). The
higher the score, the more risk factors for PPD a subject has.
Maternal attachment was assessed using  the Maternal Antenatal Attachment Scale
(MAAS). These 19-item (for mother) scales consist of two underlying
dimensions: the quality and the preoccupation of antenatal attachment
derived from factor analysis studies. The first dimension refers to affective
experiences and positive feelings about the fetus, the second one assessed
the intensity of preoccupation with the fetus, such as the strength of
feelings, the amount of time spent thinking about or dreaming about the
baby. Participants’ responses are made on 5-point scales: the higher
27
values designate a good antenatal attachment. Generally, higher scores for
both the subscales indicate the most adaptive mother–fetus attachment
style.
Anxiety symptoms were assessed using STAI-Y ( state trait anxiety
Inventory form Y-1. Self report measures of state and trait anxiety are
regularly used in studies with childbearing and, in the last time, validated
for use with pregnant and postnatal women (Grant et al., 2008). STAI-Y is a
self-administrated test that is composed by 2 parts: the state anxiety scale
consist of 20 items that evaluate current feelings  of tension and anxiety,
while the 20-item trait scale assesses anxiety levels in general.
Scores over 40 on both the state and trait  scales were adopted; this value
corresponding to the point at which false positive and negative results
were minimal (Barnett and Parker, 1986; Hart and McMahon, 2006).
The entire protocol of our study is summarized in Table 1.
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Tab1. Schedule of Assessment
Pregnancy                                 Post Partum
T
Month
T0
I
T1
III
T2
VI
T3
VIII
T4
I
T5
III
T6
VI
T7
IX
T8
XII
EPDS x x x x x x x x X
STAI_
Y
X x x x x x x x x
MAAS x x
PDPI x x x x x x x x x
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3.3. Statistical analysis
 Data are presented as means (standard deviations), or percentages.
Chi-square tests were used to compare percentages and ANOVA were
used to compare mean scores.
Using analysis of variance (ANOVA) it was possible to compare two or more
groups of data comparing the internal variability in these groups with the
variability between groups.
Furthermore, the relationship between anxiety, depression, risk factors
and maternal attachment during pregnancy were analysed using a
bivariate correlation model
Analyses were conducted using SPSS, version 15.
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4.RESULT
4.1 Demographic characteristics of the sample study
Demographic characteristics of pregnant women are provided in Table 2.
Our sample composed by 456 women whose 393 (86.2%) italian nationality
and 401 (87.9%) had a spontaneous pregnancy.  Moreover 61.6% of the
sample is composed by women in first pregnancy.
In order to evaluate if the women who completed the T2 were different
from those who did not, a t-test for indipendent sample was performed.
Women who completed the T2 had the same age of those who did not
complete it (32.6+-4.4 vs. 32.9+-5.2; t=-.48, p=.63).
The 215 ( 47.1%) women who completed the sixth month evaluation (T2)
did not differ from those who did not complete  T2 evaluation (241
52.9%)on marital status, socio-economic status, employment, living area,
Pregnancy features .
In terms of educational levels we can observe same difference between
women who complete T2 evaluation and  those who did not complete.
Tab 2 Demographic characteristics
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Age (mean ± SD) 32.75±4.84
Marital Status n
(%)
Single 26 (5.7)
Married/Cohabiting 293 (64.3)
Divorced 11 (2.4)
Widowed 1 (0.2)
Missing 37 (8.1)
Employment status
n (%)
Student 8 (1.8)
Unemployed 35 (7.7)
Employed 262 (57.5)
Housewife 46 (10.1)
Other (lavoratore
autonomo)
67 (14.7)
Missing 38 (8.3)
Educational level n
(%)
Primary school 5 (1.1)
Secondary school 74 (16.2)
High school
(completed)
206 (45.2)
University degree 132 (28.9)
Missing 39  (8.6)
Socioeconomic
status n (%)
Low 33 (7.2)
Medium 373 (81.8)
High 5 (1.1)
Missing 45 (9.9)
Living Area n (%)
Urban 176 (38.6)
Suburban 225 (49.3)
Rural 13 (2.9)
Missing 42 (9.2)
First pregnancy n
(%)
Yes 253 (55.5)
No 158 (34.6)
Missing 45 (9.9)
Pharmacological
therapy n (%)
Yes 40 (8.8)
No 360 (78.9)
Missing 56 (12.3)
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In particular we have seen that women who  completed T2 evaluation have
an higher educational levels (High school and university degree) than
those who didn’t complete the same evaluation (primary and secondary
school).
4.2 Prevalence of  depression during pregnancy.
At T0, we can observe that 4.8% of women have an high score on EPDS
(EPDS ≥13) while at T1 the percentage of the output decreases to .9%. At
T2 decreases further to .4%, while the T3 is increased up to 1.1%
4.3 Prevalence of anxiety symptoms during pregnancy.
At T0, the prevalence of anxiety is 18%, while we can observe that the
percentage decrease at the next T: T1 (6.1%), T2 (4.4%), T3 (3.9%).
4.4 Prevalence good antenatal attachment.
The average of the MAAS total scores at T2 is 76.95 ± 6.3, while at T3, the
average is 78.54 ± 6.29. Considering the MAAS preoccupation subscales at
T2 the average is 28.12 ± 4.2 and 29.33 ± 4.21 at T3. Considering the
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Quality of Attachment subscale MAAS, at T2, the average is 47.2 ± 3.29,
while the T3 is 47.71 ± 2.98.
4.5 Association during pregnancy between depression, and
anxiety symptoms good antenatal attachment , and risk factors
This table 2 was made by using EPDS ≥ 13 at T2 like independent variable
Tab. 2
Mean Std. Deviation df F p
No 47,2746 3,10615MAS_QoA.2
Si 40,0000 12,72792 1 10.036 .002
No 47,7981 3,07631MAS_QoA.3
Si 49,0000 1,41421 1 2.835 .584
No 77,0104 6,09387MAS_TOTAL.2
Si 67,5000 20,50610 1 4.576 .034
No 78,5481 6,40522MAS_TOTAL.3
Si 83,5000 2,12132 1 1.183 .279
No 28,1140 4,15174MAS_Preoccupation.2 Si 25,5000 9,19239 1 .769 .382
No 29,2308 4,18558MAS_Preoccupation.3 Si 33,0000 ,00000 1 1.607 .208
No 31,5625 6,62980STAI_STATE 2
Si 62,0000 21,21320 1 39.805 .000
No 32,5583 6,57829STAI_STATE 3
Si 43,5000 19,09188 1 5.125 .025
No 33,2606 6,80525STAI_TRAIT
Si 55,0000 . 1 10,151 .002
No 2,3989 2,33214PDPI_PRE_TOTAL.2
Si 8,0000 7,07107 1 10,923 .001
No 2,2308 2,18215PDPI_PRE_TOTAL.3
Si 4,5000 3,53553 1 2,089 .151
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This table 3 was made by using EPDS ≥ 13 at T3 like independent variable
Tab 3
Mean Std. Deviation df F p
No 47,413 2,78MAS_QoA.2
Si 38,000 11,789 1 25,186 .000
No 47,791 2,958MAS_QoA.3
Si 45,800 3,563 1 2.143 .146
No 77,288 5,918MAS_TOTAL.2
Si 65,666 14,640 1 10.246 .002
No 78,625 6,336MAS_TOTAL.3
Si 76,800 6,379 1 .398 .529
No 28,192 4,210MAS_Preoccupation.2 Si 25,666 4.041 1 1.051 .308
No 29,333 4,276MAS_Preoccupation.3 Si 29.600 3,049 1 .019 .891
No 31,817 7.275STAI_STATO.2
Si 45,000 7.549 1 9.560 .003
No 32,570 6,595STAI_STATO.3
Si 50.800 8.700 1 35.829 .000
No 33,533 6,736STAI_TRATTO
Si 47.250 15.924. 1 14,389 .000
No 2,270 2,304PDPI_PRE_TOTAL.2
Si 5,0000 3.605 1 14,389 .049
No 2,231 2,249PDPI_PRE_TOTAL.3
Si 8.750 5.315 1 28, 801 .000
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This table 4 was made by using STAI-Y ≥ 40 at T2 like independent variable
Tab 4
Mean Std. Deviation df F p
No 47.585 2,454MAS_QoA.2
Si 43.631 6.651 1 27.948 .000
No 47,828 3.136MAS_QoA.3
Si 47.750 1.488 1 .005 .945
No 77,471 5,686MAS_TOTAL.2
Si 72.000 9.469 1 13.620 .000
No 78.606 6,544MAS_TOTAL.3
Si 79.375 3.420 1 .107 .744
No 28,289 4,181MAS_Preoccupation.2 Si 25,526 4.350 1 3.026 .084
No 29,262 4,282MAS_Preoccupation.3 Si 30.125 2.295 1 .315 .576
No 2.337 2.520EPDS T2
Si 8.736 5.576 1 80.956 .000
No 2.252 2.700EPDS T3
Si 8.750 4.026 1 39.618 .000
No 2,057 1.778PDPI_PRE_TOTAL.2
Si 6.368 4.016 1 72.571 .000
No 1.949 1.825PDPI_PRE_TOTAL.3
Si 5.444 3.395 1 25.495 .000
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This table 5 was made by using STAI-Y ≥ 40 at T3 like independent variable
Tab.5
Mean Std. Deviation df F p
No 47.536 2.646MAS_QoA.2
Si 44.538 6.715 1 9.691 .002
No 47.798 3.060MAS_QoA.3
Si 47.176 2.429 1 .637 .426
No 77,218 5,986MAS_TOTAL.2
Si 75.320 9.248 1 1.126 .291
No 78.541 6.546MAS_TOTAL.3
Si 78.588 4.528 1 .001 .976
No 27.981 4.306MAS_Preoccupation.2 Si 29.000 3.763 1 .665 .416
No 29.238 4.394MAS_Preoccupation.3 Si 29.941 2.771 1 .408 .524
No 2.605 3.466EPDS T2
Si 6.769 2.919 1 17.255 .000
No 2.045 2.374EPDS T3
Si 9.235 5.706 1 83.426 .000
No 2,093 1.950PDPI_PRE_TOTAL.2
Si 4.500 3.371 1 13.845 .000
No 2.178 2.177PDPI_PRE_TOTAL.3
Si 5.000 4.082 1 18.086 .000
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4.6 Association  during pregnancy beetween antenatal maternal
attachment and demographic characteristics
In our sample we don’t find any association between antenatal maternal
attachment and demographic characteristics except for women  in their
first pregnancy in which we discover higher MAAS scores than other
women in sample. These data are shown in Table 6
Tab.6
N Mean Std.Deviation df F p
No 59 46,5424 3,23942MAS_QoA.2
Si 123 47,6179 3,32531 1 4.241 .041
No 40 46,9000 4,21110MAS_QoA.3
Si 78 48,2436 1,91498 1 5.685 .019
No 59 74,9831 6,70433MAS_TOTAL.2
Si 123 77,9837 6,02724 1 9.181 .003
No 40 76,2250 7,87885MAS_TOTAL.3
Si 78 79,8718 4,81707 1 9.694 .002
No 59 26,7288 4,70814MAS_Preoccupation.2
Si 123 28,7886 3,87563 1 9.766 .002
No 40 27,7250 4,71216MAS_Preoccupation.3
Si 78 30,1538 3,69653 1 9.433 .003
As a result of these data, we further investigated the possible relationship
between primiparous, anxiety, depression and risk factors. These data are
shown in Table 7
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Tab.7
4.7 Correlation between antenatal attachment, anxiety,
depression and risk factors during pregnancy
The results below represent (table 8) the values of correlation between the
variables of antenatal attachment, depression, anxiety and risk factors in
the antenatal:
Tab 8.1
Eta
MAS_
TOTA
L.2
MA
S_
Qo
A.2
MAS
_Pre
occu
patio
n.2
MAS
_TO
TAL.
3
MAS
_Qo
A.3
MAS_
Preoc
cupati
on.3
Eta Pe
ars
on
Co
rrel
ati
on
1
-
,263(*
*)
-
,17
8(*)
-
,272(
**)
-
,313(
**)
-
,258(
**)
-
,300(*
*)
Sig
.
(2-
tail
ed)
,000 ,017 ,000 ,001 ,005 ,001
N Mean Std.Deviation df F p
EPDS_TOT.2 No 59 3,3220 3,01399
Si 122 2,6721 3,58934 1 1.442 .231
EPDS_TOT.3 No 40 3,9750 4,64917
Si 78 2,3846 3,33899 1 4.560 .035
STAI_STATO.2 No 60 32,8333 6,65408
Si 128 31,4063 7,57788 1 1.823 .179
STAI_STATO.3 No 43 35,3256 7,86106
Si 92 31,9783 6,91388 1 1.715 .193
PDPI_PRE_TOTAL.2 No 57 2,8596 2,51736
Si 124 2,3226 2,47113 1 1.562 .213
PDPI_PRE_TOTAL.3 No 38 2,9737 2,89909
Si 81 2,2963 2,49722 1 6.287 .013
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Tab8.2
Eta
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_ST
ATO.
0
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1
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Tab 8.3
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-
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-
,378(
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-
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-,011
Sig
.
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Tab8.4
STAI
_ST
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0
STAI
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1
STAI
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2
STAI
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3
STAI
_ST
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-
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**)
-
,291(
**)
-
,360(
**)
-,164
-
,433(
**)
-
,243(
**)
Sig
.
(2-
tail
ed)
,008 ,000 ,000 ,070 ,001 ,001
N 189 155 195 123 58 190
MA
S_
Qo
A.2
Pe
ars
on
Co
rrel
ati
on
-
,283(
**)
-
,364(
**)
-
,450(
**)
-
,314(
**)
-
,465(
**)
-
,286(
**)
Sig
.
(2-
tail
ed)
,000 ,000 ,000 ,000 ,000 ,000
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Tab 8.5
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0
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3
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-
,192(
*)
-
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-
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Sig
.
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ed)
,205 ,391 ,969 ,032 ,000 ,092 ,342 ,486 ,128 ,000 ,063
N 120 90 106 125 47 122 91 107 126 62 122
MA
S_
Qo
A.3
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on
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-
,181(
*)
-
,256(
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-,148
-
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-
,561(
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-
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*)
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-
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-
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-
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.
(2-
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N 117 107 107 107 126 126 126 120 90 106 125
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Tab8.6
Eta
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Tab 8.7
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Tab 8.8
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Tab 8.10
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5. DISCUSSION
Including a study as a protective factor: The results suggest that women who
have been taken over by the service from the Perinatal Research Unit and
Screening Study (PND-Rescue). seem to be affected to a lesser extent than
epidemiological data, anxiety and depression during the pregnancy period.
This could, presumably, depend on the actual quality of the service that
performs in a continuous and constant monitoring by staff and experienced
and qualified professionals in the recognition, diagnosis and subsequent
treatment of specific diseases encountered during pregnancyn particular, this
service provides, in addition to the primary observation, the possibility of
specific treatment as  support the psychological and psychopharmacological
customized to each pregnancy. Earlier diagnosis seems to be able to provide
fast care of pregnant women with an immediate administration (T0) of
specific screening tests.
Trend of Depression and Anxiety during pregnancy:
Although at the time of initial evaluation (T0), levels of anxiety and
depression scores found were similar to those described in the literature,
in the following months (T1, T2) we have seen a gradual but significant
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decrease in these values due partly to the inclusion in the study with the
same treatments related to it.
Specifically, with the approaching time of delivery (T3), we can see a slight
increase   the depressive component . The anxiety component, however,
does not seem to be sensitive to these issues by maintaining a progressive
decrease throughout pregnancy (T0-T3). This finding might suggest that the
same participation in the study represents a protective factor that can
influence the size more anxious than depressive.
 Antenatal attachment, depression and anxiety:
Analysis of the results obtained from the assessment of attachment between
mother and fetus, possible to examine the protective role with respect to the
onset of diseases of anxiety or depression. In particular, the qualitative
dimension of attachment appear to affect, in the vicinity of the sixth month
of gestation, the component of depressive and anxious, because a better
quality of attachment seems likely to be a protective factor with respect to
the manifestation of symptoms of depression / anxiety during pregnancy. It
does not appear to affect the quality of attachment , however , the symptoms
anxious /depressives near delivery .
From our data, we can see also that the variable Attachment Preoccupation
component does not seem to influence either the anxious or depressive. So
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we can assume that all the concerns about the fetus does not represent a
clear risk factor. On the contrary, it is conceivable that the quality of
attachment represents a risk factor to be taken into account during the early
stage of screening. This hypothesis suggests the possible need to perform
more frequent monitoring on pregnant women in order to better specify a
number of risk factors can that be inserted in a specific screening protocol
on the quality attachment.
Primiparous versus Multiparous:
Contrary to previous reports (Condon & Esuvaranathan, 1990).
mothers in their first pregnancy seem to have higher levels of attachment
compared to multiparae.
This result may be partly explained by differences in lifestyle (quantity and
quality of time spent with your thoughts on the developing fetus) and seems
to affect depressive symptoms in the last trimester of gestation, confirming
the hypothesis that 'maternal attachment toward the fetus can be considered
a protective factor. This finding is strengthened by the fact/result from
having found that first-time mothers found to have lower scores due to risk
factors compared to multiparous near term (T3).
Correlation between  antenatal attachment , depression,
anxiety and risk  factors during pregnancy.
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To check the intensity and direction of the relationships between depression,
anxiety, attachment to the fetus and risk factors, was performed Pearson
bivariate correlation.
First we found a positive correlation between age and levels of state anxiety
at the time of inclusion in the study, in the first quarter and after the birth of
children (T0, T1 and T4) and stroke. This finding allows us to hypothesize
that increasing age, the woman is suffering more anxiety related to the
management of pregnancy and childbirth.
Was also noted that younger women establish a better attachment with the
fetus, probably because they are less anxious towards the course of
gestation.
The MAAS tot recorded during the second trimester of pregnancy (T2)
seems to confirm the data obtained previously, noting a negative correlation
between levels of attachment,  values of depression and anxiety throughout
the pregnancy period.
Furthermore, the data collected, suggest that treatment of anxiety can be
predictive of a correct development of attachment to the fetus as well as
suffer from a few specific risk factors (recorded by PDPI).
Finally, with regard to the levels of attachment to the third trimester (T3),
confirming the trend towards a negative correlation with levels of
depression even in the postpartum period (T4).
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Going in particular, the analysis of the qualitative aspects of attachment, in
the second and third trimesters of pregnancy, the data collected confirm a
negative correlation between attachment and depressive symptoms, anxiety
(state and trait) and risk factors throughout the gestation period and after
childbirth.
As for issues of concern in the area of attachment during the third quarter, it
is possible that they may constitute potential risk factors for the onset of
depression or anxiety in post-partum.
As confirmed by the literature, there is a positive correlation between
anxiety, depression and risk factors.
From the collection of all of these data, it can be concluded that the third
trimester of pregnancy appear more likely to be sensitive to the period
throughout the pregnancy. This might be justifiable in terms of metabolic-
hormonal changes, the possibility that the mother steps from a idealized
image of their child to a realistic representation of their child. In addition, a
further factor of significant importance can be represented by the net change
in terms of lifestyle where pregnant women are facing near most recently
stored data trimester of pregnancy.
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Limitations of present study
The limitations of present study primarily consists of the scarcity of data
collected in the postpartum period (T4) and the absence of definitive
follow-up to a year after delivery.
Furthermore, another limitation is the difficulty of having to draw together
data that describe qualitative and quantitative in the post-partum period,
in order to observe a continuity between attachment to the fetus or child.
A further limitation is the absence of a control group of pregnant women
because it is impossible ethically to exclude from the treatment of these
women.
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6. CONCLUSION
Many of the physiological sensations that occur during pregnancy closely
resemble anxiety symptoms; thus, these disorders may be masked in
pregnant women. For this reason it is essential that treatment providers in
obstetric offices, primary care settings, and mental health clinics be
attuned to the signs of anxiety disorders (Weisberg and Paquette, 2002).
Moreover, it is important to differentiate between manageable antenatal
anxiety and depression occurring as  transition to parenthood and the
more debilitating antenatal anxiety and depression condition that require
specific assessment and treatment by a mental health professional as
others have noted (Austin, 2003; Austin et al., 2005; Glover and O’Connor,
2002), it may be just as important to focus on the detection and treatment
of perinatal anxiety, given its significant association with the development
of subsequent postnatal depression.Pregnancy may be an ideal time for
intervention, to mitigate the mother’s suffering and to reduce the long-
term consequences of an untreated mental disorder. Carrying out
antenatal screening of established risk factors and accurate evaluation of
attachment during pregnancy may help to plan adequate treatment in
order to prevent possible postpartum distress outcomes. Further studies
are needed to replicate our findings and to clarify the role of  pre/post
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natal attachment during pregnancy and its link with Post-Partum
Depression in order to identify a specific subgroup of women warranting
special attention.
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